60 Degrees Pharmaceuticals, Inc. (SXTP)
$0.97+0.00%Close
BUYCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $782,354
- Beta
- 2.40
- P/E (TTM)
- -0.18
- Short % float
- 17.07%
- Days to cover
- 1.6
- SI change
- -38.3%
- 1W
- -30.22%
- 1M
- +4.30%
- vs SPY 1W
- -31.38%
- vs SPY 1M
- +1.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SXTP?
- LOPJLB’s latest quantitative signal on 60 Degrees Pharmaceuticals, Inc. (SXTP) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is SXTP in?
- 60 Degrees Pharmaceuticals, Inc. (SXTP) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does 60 Degrees Pharmaceuticals, Inc. (SXTP) do?
- 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafenoquine, in its 'Arakoda regimen' formulation, is …